Continue to site >
Trending ETFs

INVESCO Health Care Fund

mutual fund
GGHYX
Payout Change
Suspended
Price as of:
$40.12 -0.47 -1.16%
primary theme
Health Care Sector Equity
GGHYX (Mutual Fund)

INVESCO Health Care Fund

Payout Change
Suspended
Price as of:
$40.12 -0.47 -1.16%
primary theme
Health Care Sector Equity
GGHYX (Mutual Fund)

INVESCO Health Care Fund

Payout Change
Suspended
Price as of:
$40.12 -0.47 -1.16%
primary theme
Health Care Sector Equity

Name

As of 12/12/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$40.12

$1.35 B

0.00%

0.81%

Vitals

YTD Return

6.7%

1 yr return

8.1%

3 Yr Avg Return

0.3%

5 Yr Avg Return

5.3%

Net Assets

$1.35 B

Holdings in Top 10

46.7%

52 WEEK LOW AND HIGH

$40.6
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 0.81%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A


Min Investment

Standard (Taxable)

$1,000

IRA

$250


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 12/12/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$40.12

$1.35 B

0.00%

0.81%

GGHYX - Profile

Distributions

  • YTD Total Return 6.7%
  • 3 Yr Annualized Total Return 0.3%
  • 5 Yr Annualized Total Return 5.3%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.01%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    INVESCO Health Care Fund
  • Fund Family Name
    INVESCOFDS
  • Inception Date
    Oct 03, 2008
  • Shares Outstanding
    N/A
  • Share Class
    Y
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Justin Livengood

Fund Description

The Fund invests, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of issuers engaged primarily in health care-related industries, and in derivatives and other instruments that have economic characteristics similar to such securities.
The Fund will concentrate its investments in the securities of domestic and foreign issuers in the health care industry. The Fund uses various criteria to determine whether an issuer is engaged in health care-related industries, including whether (1) it derives 50% or more of its gross income or its net sales from activities in the health care industry; (2) it devotes 50% or more of its assets to producing revenues from the health care industry; or (3) based on other available information, the Fund’s portfolio manager determines that its primary business is within the health care industry. Such other available information may include industry classifications from any one or more third-party providers, such as those using the Global Industry Classification Standard (GICS®), the North American Industry Classification System (NAICS), or the Bloomberg Industry Classification System (BICS).
Issuers engaged in health care-related industries include those that design, provide, distribute, manufacture, or sell products or services used for or in connection with health care or medicine (such as pharmaceutical issuers, biotechnology research firms, companies that make or sell medical products, and companies that own or operate health care facilities and systems).
The Fund invests primarily in equity securities, including common and preferred stock, and depositary receipts.
The Fund may invest in the securities of issuers of all capitalization sizes and may invest a significant amount of its net assets in the securities of small- and mid-capitalization issuers.
The Fund may invest in securities of foreign issuers including up to 20% of its net assets in securities of issuers located in emerging markets countries, i.e., those that are generally in the early stages of their industrial cycles.
The Fund can invest in derivative instruments, including forward foreign currency contracts. The Fund can use forward foreign currency contracts to hedge against adverse movements in the foreign currencies in which portfolio securities are denominated.
In selecting securities for the Fund, the portfolio manager uses a research-oriented bottom-up investment approach,focusing on issuer fundamentals before considering the impact of overall economic,market or industry trends.This approach includes analysis of a company's financial statements and management structure andconsideration of the company's operations,product development, and itsindustry position.The portfolio manager currently focuses on companies that the portfolio manager believes are characterized by industry leadership, market share growth, high
caliber management teams, sustainable competitive advantages, and strong growth themes or new innovative products or services.The portfolio manager monitors individual issuers for changes in the factors above, which may trigger a decision to sell a security,but does not require a decision to do so. The factors considered by the portfolio manager may vary in particular cases and may change over time.
Read More

GGHYX - Performance

Return Ranking - Trailing

Period GGHYX Return Category Return Low Category Return High Rank in Category (%)
YTD 6.7% -19.2% 22.7% 45.91%
1 Yr 8.1% -6.7% 34.5% 46.54%
3 Yr 0.3%* -23.9% 12.6% 62.50%
5 Yr 5.3%* -8.5% 13.0% 64.43%
10 Yr 5.4%* -0.3% 13.0% 75.68%

* Annualized

Return Ranking - Calendar

Period GGHYX Return Category Return Low Category Return High Rank in Category (%)
2023 4.2% -12.6% 19.0% 28.30%
2022 -13.3% -53.9% 3.2% 60.53%
2021 -9.9% -39.6% 24.2% 73.03%
2020 7.5% -13.6% 178.2% 73.15%
2019 27.5% 3.8% 63.8% 12.78%

Total Return Ranking - Trailing

Period GGHYX Return Category Return Low Category Return High Rank in Category (%)
YTD 6.7% -19.2% 22.7% 45.91%
1 Yr 8.1% -6.7% 34.5% 46.54%
3 Yr 0.3%* -23.9% 12.6% 62.50%
5 Yr 5.3%* -8.5% 13.0% 64.43%
10 Yr 5.4%* -0.3% 13.0% 75.68%

* Annualized

Total Return Ranking - Calendar

Period GGHYX Return Category Return Low Category Return High Rank in Category (%)
2023 4.2% -12.6% 19.0% 46.54%
2022 -13.3% -53.9% 3.7% 73.68%
2021 12.5% -33.9% 26.0% 31.58%
2020 14.7% -0.7% 180.6% 75.17%
2019 32.2% 4.6% 63.8% 22.56%

NAV & Total Return History


GGHYX - Holdings

Concentration Analysis

GGHYX Category Low Category High GGHYX % Rank
Net Assets 1.35 B 6.66 M 45.7 B 35.22%
Number of Holdings 80 25 430 49.06%
Net Assets in Top 10 643 M 2.12 M 23.9 B 32.70%
Weighting of Top 10 46.65% 18.4% 78.1% 49.69%

Top 10 Holdings

  1. Eli Lilly and Co. 8.50%
  2. Boston Scientific Corp. 5.80%
  3. UnitedHealth Group Inc. 5.23%
  4. McKesson Corp. 4.28%
  5. Danaher Corp. 4.24%
  6. Vertex Pharmaceuticals Inc. 3.89%
  7. Intuitive Surgical, Inc. 3.82%
  8. Merck Co., Inc. 3.72%
  9. AstraZeneca PLC, ADR 3.63%
  10. Regeneron Pharmaceuticals, Inc. 3.56%

Asset Allocation

Weighting Return Low Return High GGHYX % Rank
Stocks
96.52% 89.92% 106.13% 76.10%
Cash
7.61% 0.00% 33.01% 10.69%
Preferred Stocks
0.00% 0.00% 7.86% 34.59%
Other
0.00% -22.99% 23.24% 38.99%
Convertible Bonds
0.00% 0.00% 0.37% 11.69%
Bonds
0.00% 0.00% 12.39% 32.08%

Stock Sector Breakdown

Weighting Return Low Return High GGHYX % Rank
Healthcare
100.00% 59.26% 100.00% 1.30%
Utilities
0.00% 0.00% 0.00% 4.55%
Technology
0.00% 0.00% 22.69% 11.69%
Real Estate
0.00% 0.00% 5.89% 8.44%
Industrials
0.00% 0.00% 7.02% 10.39%
Financial Services
0.00% 0.00% 1.60% 29.87%
Energy
0.00% 0.00% 0.00% 4.55%
Communication Services
0.00% 0.00% 9.11% 7.79%
Consumer Defense
0.00% 0.00% 25.73% 13.64%
Consumer Cyclical
0.00% 0.00% 1.92% 10.39%
Basic Materials
0.00% 0.00% 7.16% 35.06%

Stock Geographic Breakdown

Weighting Return Low Return High GGHYX % Rank
US
91.08% 61.27% 104.41% 56.60%
Non US
5.43% 0.00% 34.10% 38.36%

GGHYX - Expenses

Operational Fees

GGHYX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.81% 0.08% 4.48% 64.78%
Management Fee 0.63% 0.03% 1.25% 35.22%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

GGHYX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

GGHYX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

GGHYX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 238.00% 9.43%

GGHYX - Distributions

Dividend Yield Analysis

GGHYX Category Low Category High GGHYX % Rank
Dividend Yield 0.00% 0.00% 6.24% 40.88%

Dividend Distribution Analysis

GGHYX Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annual Annual Annual

Net Income Ratio Analysis

GGHYX Category Low Category High GGHYX % Rank
Net Income Ratio 0.01% -2.54% 1.85% 31.58%

Capital Gain Distribution Analysis

GGHYX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Distributions History

View More +

GGHYX - Fund Manager Analysis

Managers

Justin Livengood


Start Date

Tenure

Tenure Rank

Dec 18, 2020

1.45

1.5%

Mr. Livengood has been a Vice President of OppenheimerFunds since May 2006 and a Senior Portfolio Manager since January 2014. He was a Senior Research Analyst from May 2006 to January 2014, responsible for the health care, energy and financial services sectors for mid- and small-cap growth accounts. Before joining OppenheimerFunds in May 2006, Mr. Livengood was a vice president and fund analyst with Merrill Lynch Investment Managers. During his tenure at Merrill Lynch he also worked as an investment banking analyst in the Global Media Group and as an associate with Merrill Lynch Ventures.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.88 0.25